Murine complement interactions with Pseudomonas aeruginosa and their consequences during pneumonia

被引:35
|
作者
Younger, JG
Shankar-Sinha, S
Mickiewicz, M
Brinkman, AS
Valencia, GA
Sarma, JV
Younkin, EM
Standiford, TJ
Zetoune, FS
Ward, PA
机构
[1] Univ Michigan, Dept Emergency Med, Ann Arbor, MI USA
[2] Univ Michigan, Dept Pathol, Ann Arbor, MI USA
[3] Univ Michigan, Div Pulm & Crit Care Med, Ann Arbor, MI USA
关键词
D O I
10.1165/rcmb.2002-0145OC
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Complement is necessary for defense against lung infection with Pseudomonas aeruginosa in mice. We studied in vitro interactions between complement and P. aeruginosa and in vivo effects of complement depletion to better understand this relationship. In vitro, P. aeruginosa strain UI-18 was resistant to killing by mouse serum. However, C3 opsonized the organism (via the alternative and mannose binding lectin [MBL] pathways), and C5 convertase activity on the bacterial surface was demonstrated. In vivo, compared with normal mice, complement-deficient mice experienced higher mortality and failed to sterilize their bronchoalveolar space within 24 h of inoculation. These changes did not seem to be a result of decreased inflammation because complement-deficient mice had normal neutrophil recruitment, greater lung myeloperoxidase content, and, by 24 h, a 35-fold higher level of the CXC chemokine KC. Lung static pressure-volume curves were abnormal in infected animals but were significantly more so in complement deficient mice. These data indicate that although P. aeruginosa is resistant to serum killing, C3 opsonization and C5 convertase assembly occur on its surface. This interaction in vivo plays a central role in host survival beyond just recruitment and activation of phagocytes and may serve to limit the inflammatory response to and tissue injury resulting from bacterial infection.
引用
收藏
页码:432 / 438
页数:7
相关论文
共 50 条
  • [21] Characterization of the onset and consequences of pneumonia due to fluoroquinolone-susceptible or -resistant Pseudomonas aeruginosa
    Paladino, JA
    Sunderlin, JL
    Forrest, A
    Schentag, JJ
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (03) : 457 - 463
  • [22] Subversion of the Complement System by Pseudomonas aeruginosa
    Hastings, Cody James
    Syed, Shazrah Salim
    Marques, Claudia Nogueira Hora
    JOURNAL OF BACTERIOLOGY, 2023, 205 (08)
  • [23] The alternative activation pathway and complement component C3 are critical for a protective immune response against Pseudomonas aeruginosa in a murine model of pneumonia
    Mueller-Ortiz, SL
    Drouin, SM
    Wetsel, RA
    INFECTION AND IMMUNITY, 2004, 72 (05) : 2899 - 2906
  • [24] Beneficial effect of adjunctive azithromycin in treatment of mucoid Pseudomonas aeruginosa pneumonia in the murine model
    Nicolau, DP
    Banevicius, MA
    Nightingale, CH
    Quintiliani, R
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (12) : 3033 - 3035
  • [25] Vinculin Accumulates Pulmonary Interstitial Neutrophils in a Murine Model of Acute Pseudomonas aeruginosa Pneumonia
    Wilson, Z. S.
    Neumann, B. M.
    Odzer, J.
    Lefort, C. T.
    AMERICAN JOURNAL OF PATHOLOGY, 2018, 188 (10): : 2432 - 2432
  • [26] Obesity Inhibits Innate Immune Functions During Pseudomonas aeruginosa Pneumonia
    Huizinga, Gabrielle P.
    Warheit-Niemi, Helen I.
    Gallagher, Katherine
    Moore, Bethany B.
    Singer, Kanakadurga
    JOURNAL OF IMMUNOLOGY, 2022, 208 (01):
  • [27] Pseudomonas aeruginosa Nosocomial Pneumonia: Impact of Pneumonia Classification
    Micek, Scott T.
    Kollef, Marin H.
    Torres, Antoni
    Chen, Catherine
    Rello, Jordi
    Chastre, Jean
    Antonelli, Massimo
    Welte, Tobias
    Clair, Bernard
    Ostermann, Helmut
    Calbo, Esther
    Wunderink, Richard
    Menichetti, Francesco
    Schramm, Garrett
    Menon, Vandana
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2015, 36 (10): : 1190 - 1197
  • [28] PSEUDOMONAS-AERUGINOSA PNEUMONIA IN ADULTS
    ROSE, HD
    HECKMAN, MG
    UNGER, JD
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1973, 107 (03): : 416 - 422
  • [29] Role of apoptosis in Pseudomonas aeruginosa pneumonia
    Hotchkiss, RS
    Dunne, WM
    Swanson, PE
    Davis, CG
    Tinsley, KT
    Chang, KC
    Buchman, TG
    Karl, IE
    SCIENCE, 2001, 294 (5548) : U1 - U2
  • [30] Update on the treatment of Pseudomonas aeruginosa pneumonia
    El Solh, Ali A.
    Alhajhusain, Ahmad
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 64 (02) : 229 - 238